or B-VEC), a topical gene therapy for treating wounds in patients with dystrophic epidermolysis bullosa (DEB) who have specific genetic mutations. The recommendation allows for administration in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback